Latest Insider Transactions at Day One Biopharmaceuticals, Inc. (DAWN)
This section provides a real-time view of insider transactions for Day One Biopharmaceuticals, Inc. (DAWN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Day One Biopharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Day One Biopharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2024
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
30,000
-2.82%
|
$390,000
$13.31 P/Share
|
|
Nov 18
2024
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
10,554
-8.87%
|
$137,202
$13.21 P/Share
|
|
Nov 18
2024
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
2,602
-1.07%
|
$33,826
$13.21 P/Share
|
|
Nov 18
2024
|
Adam Dubow GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
3,165
-8.96%
|
$41,145
$13.21 P/Share
|
|
Nov 18
2024
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
2,206
-0.21%
|
$28,678
$13.21 P/Share
|
|
Nov 15
2024
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
19,999
+5.52%
|
-
|
|
Nov 15
2024
|
Charles N York Ii COO, CFO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
10,250
+1.4%
|
-
|
|
Nov 15
2024
|
Adam Dubow GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
8,399
+7.9%
|
-
|
|
Nov 15
2024
|
Samuel C. Blackman HEAD OF R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,686
+0.27%
|
-
|
|
Nov 11
2024
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
10,000
-0.94%
|
$160,000
$16.1 P/Share
|
|
Nov 08
2024
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
18,255
-1.68%
|
$292,080
$16.17 P/Share
|
|
Nov 07
2024
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
11,245
-1.03%
|
$179,920
$16.03 P/Share
|
|
Oct 31
2024
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
500
-0.05%
|
$8,000
$16.02 P/Share
|
|
Sep 10
2024
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
30,000
-2.66%
|
$420,000
$14.22 P/Share
|
|
Aug 16
2024
|
Adam Dubow GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
3,202
-10.63%
|
$44,828
$14.0 P/Share
|
|
Aug 16
2024
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
2,633
-1.12%
|
$36,862
$14.0 P/Share
|
|
Aug 16
2024
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
2,232
-0.2%
|
$31,248
$14.0 P/Share
|
|
Aug 16
2024
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
10,681
-9.74%
|
$149,534
$14.0 P/Share
|
|
Aug 15
2024
|
Adam Dubow GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
8,399
+9.27%
|
-
|
|
Aug 15
2024
|
Charles N York Ii COO, CFO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
10,250
+1.44%
|
-
|
|
Aug 15
2024
|
Samuel C. Blackman HEAD OF R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,686
+0.26%
|
-
|
|
Aug 15
2024
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
19,999
+5.98%
|
-
|
|
Jul 16
2024
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
20,000
-1.75%
|
$320,000
$16.01 P/Share
|
|
Jul 02
2024
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
BUY
Bona fide gift
|
Indirect |
241,912
+7.78%
|
-
|
|
Jul 02
2024
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Bona fide gift
|
Indirect |
241,912
-23.03%
|
-
|
|
Jun 21
2024
|
Saira Ramasastry |
SELL
Open market or private sale
|
Direct |
10,000
-19.81%
|
$130,000
$13.19 P/Share
|
|
Jun 10
2024
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
30,000
-2.56%
|
$360,000
$12.62 P/Share
|
|
May 16
2024
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
7,873
-1.19%
|
$125,968
$16.08 P/Share
|
|
May 16
2024
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
2,675
-1.18%
|
$42,800
$16.08 P/Share
|
|
May 16
2024
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
2,267
-0.19%
|
$36,272
$16.08 P/Share
|
|
May 16
2024
|
Adam Dubow GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
3,253
-13.02%
|
$52,048
$16.08 P/Share
|
|
May 15
2024
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
19,999
+1.0%
|
-
|
|
May 15
2024
|
Charles N York Ii COO, CFO AND SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
10,250
+1.49%
|
-
|
|
May 15
2024
|
Samuel C. Blackman HEAD OF R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,686
+0.25%
|
-
|
|
May 15
2024
|
Adam Dubow GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
8,399
+11.2%
|
-
|
|
May 10
2024
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
10,000
-0.85%
|
$160,000
$16.37 P/Share
|
|
May 03
2024
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
9,154
-1.4%
|
$155,618
$17.85 P/Share
|
|
May 03
2024
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
8,078
-3.58%
|
$137,326
$17.85 P/Share
|
|
May 02
2024
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
6
-0.0%
|
$102
$17.94 P/Share
|
|
May 02
2024
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
200
-0.09%
|
$3,400
$17.9 P/Share
|
|
May 01
2024
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
70,051
-9.7%
|
$1,190,867
$17.88 P/Share
|
|
May 01
2024
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
52,183
-18.79%
|
$887,111
$17.89 P/Share
|
|
Apr 18
2024
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
10,000
-0.84%
|
$160,000
$16.02 P/Share
|
|
Mar 25
2024
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
10,000
-0.84%
|
$160,000
$16.01 P/Share
|
|
Mar 11
2024
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
30,000
-2.45%
|
$450,000
$15.24 P/Share
|
|
Feb 27
2024
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
20,000
-1.61%
|
$320,000
$16.11 P/Share
|
|
Feb 16
2024
|
Adam Dubow GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
3,242
-16.35%
|
$48,630
$15.25 P/Share
|
|
Feb 16
2024
|
Charles N York Ii COO, CFO AND SECRETARY |
SELL
Open market or private sale
|
Direct |
2,666
-0.95%
|
$39,990
$15.25 P/Share
|
|
Feb 16
2024
|
Samuel C. Blackman HEAD OF R&D |
SELL
Open market or private sale
|
Direct |
2,258
-0.18%
|
$33,870
$15.25 P/Share
|
|
Feb 16
2024
|
Jeremy Bender CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
7,615
-1.04%
|
$114,225
$15.25 P/Share
|